KRAS and pancreatic neoplasm: Furthermore, some KRAS-driven overexpressed enzymes, such as RPIA, are still preserved in some pancreatic cancer cell lines with KRAS ablation, sustaining nonoxidative PPP and cancer cell survival in a KRAS-independent manner [50].